Stomatitis Clinical Trial
Official title:
Clinical Evaluation of an Experimental Solution Based on Ricinus Communis Compared to Sodium Hypochlorite for Denture Cleansing
Verified date | March 2015 |
Source | University of Sao Paulo |
Contact | n/a |
Is FDA regulated | No |
Health authority | Brazil: Ethics Committee |
Study type | Interventional |
This clinical trial evaluated Ricinus communis and sodium hypochlorite solutions in different concentrations for denture cleanliness, regarding biofilm removal capacity, remission of atrophic chronic candidiasis, degree of patient satisfaction and antimicrobial action against specific microorganism. Sixty-four denture wearers with absence (n=40) or presence of Candidiasis (n=24) were selected and oriented to brush their dentures with a specific brush and neutral soap for 3 minutes, 3 times a day and immerse them, once a day, in hygiene solutions (0.25% sodium hypochlorite - S1 and 0.5% - S2, 10% R. communis - S3; Saline - S4: control) during 20 minutes, for 7 days. The solutions were used in a randomized, double blind and cross form with washout periods. To quantify biofilm with software ImageTool 3.0, the inner surface was disclosed (1% neutral red) and photographed at the end of each period. The Candidiasis remission was assessed by scores before and after the use of solutions. Patient satisfaction was assessed by questionnaire. Antimicrobial activity was determined by Colony Forming Units (CFU) counts of Streptococcus mutans, Candida spp., and gram-negative microorganisms. For collecting biofilm, internal surface of each maxillary complete denture was brushed with saline solution, and the biofilm suspension obtained. After serial dilutions (100 - 10-3), 50 uL aliquots were seeded in Petri dishes containing Mitis salivarius agar base, CHROMagar Candida® and MacConkey agar for detecting S. mutans, Candida spp., or gram-negative microorganisms, respectively. After incubation, colonies were counted, and values in CFU/mL were calculated. Biofilm removal was analyzed as a split-plot with two variation factors: inflammation and solutions. The candidiasis remission was analyzed after adjustment using multinomial logistic regression. Logistic regression analysis and compound symmetry was adopted for patient satisfaction. The antimicrobial action was analyzed with Friedman´s test. Antimicrobial action data were processed after transformation - log10 (CFU + 1) - and were analyzed by Friedman test (α = 0.05).
Status | Completed |
Enrollment | 64 |
Est. completion date | December 2013 |
Est. primary completion date | June 2013 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 45 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Edentulous that make regular use of dentures in acrylic resin for at least one year with the presence of biofilm. Exclusion Criteria: - Problems in adapting, reline, or repair fractures - Patients with limited communication or collaboration as the following recommended protocol. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Supportive Care
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University of Sao Paulo | Coordenação de Aperfeiçoamento de Pessoal de Nível Superior., Fundação de Amparo à Pesquisa do Estado de São Paulo |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | biofilm removal capacity using Image Tool software | 7 days | Yes | |
Primary | antimicrobial action against specific microorganisms by Colony Forming Units counts | 7 days | Yes | |
Secondary | remission of atrophic chronic candidiasis using multinomial logistic regression analysis | 7 days | Yes | |
Secondary | degree of patient satisfaction assessed by specific questionnaire | 7 days | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02229136 -
Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by Everolimus
|
Phase 2 | |
Completed |
NCT02762019 -
Laser for Oral Mucositis in Pediatric Onco-hematology
|
Phase 3 | |
Recruiting |
NCT02945878 -
Predictive Factors of Acute Oral Mucositis Induced by Chemo-radiotherapy for Local Advanced Nasopharyngeal Carcinoma
|
N/A | |
Recruiting |
NCT05878405 -
Methylene Blue Mouthwash for the Treatment of Oral Mucositis Pain in Patients With Cancer
|
Phase 3 | |
Completed |
NCT00323518 -
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
|
Phase 2 | |
Terminated |
NCT02326675 -
Cryotherapy in the Prevention of Chemotherapy-Induced Mucositis in Stem Cell Transplant
|
N/A | |
Active, not recruiting |
NCT01099891 -
The Clinical Study for Evaluation of Efficacy and Safety of EGF on Oral Mucositis in Radiation Therapy Patients
|
Phase 3 | |
Terminated |
NCT01092975 -
Safety of Phenylephrine for Oral Mucositis Prevention
|
Phase 1 | |
Terminated |
NCT00031551 -
Evaluation of Efficacy and Mechanisms of an Antiinflammatory Intervention for Chemotherapy Related Mucosal Injury
|
Phase 2 | |
Completed |
NCT00385515 -
Efficacy of SNX-1012 in the Treatment of Oral Mucositis
|
Phase 2 | |
Completed |
NCT03200340 -
EC-18 for Oral Mucositis in Patients With Concomitant Chemoirradiation
|
Phase 2 | |
Not yet recruiting |
NCT05323058 -
The Use of Tulsi Extract for The Management of Oral Mucositis in Head & Neck Cancer Patients Undergoing Radiotherapy
|
Phase 2 | |
Completed |
NCT01837446 -
Morphine Mouthwash for Management of Oral Mucositis in Patients With Head and Neck Cancer
|
Phase 2/Phase 3 | |
Completed |
NCT00104065 -
Safety and Efficacy of CG53135-05 in the Prevention of Oral Mucositis in Patients Receiving Bone Marrow Transplant
|
Phase 2 | |
Completed |
NCT03469284 -
MOM's PAIN (Methylene Blue for Oral Mucositis' PAIN)
|
Phase 2 | |
Not yet recruiting |
NCT03778008 -
Recombinant Bovine Basic Fibroblast Growth Factor for the Treatment of Radiation Induced Oral Mucositis
|
Phase 2 | |
Terminated |
NCT00075023 -
Effectiveness of Topical Thalidomide to Treat Chronic Graft-Versus-Host-Disease Related Stomatitis
|
Phase 2 | |
Not yet recruiting |
NCT05010928 -
Using Tea-based Mouthwash Relieve Stomatitis and Oral Ulcers
|
Phase 2 | |
Active, not recruiting |
NCT00101582 -
Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer
|
Phase 3 | |
Recruiting |
NCT06071637 -
Low Power Laser Therapy As Prevention Of Oral Mucositis And Oropharyngeal Pain In Patients Undergoing Allogenetic HSCT
|
Phase 3 |